COMMUNIQUÉS West-GlobeNewswire

Tourmaline Bio Announces Proposed Public Offering of Common Stock
24/01/2024
NEW YORK, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (“Tourmaline”) (Nasdaq: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of [...]
23andMe to Report FY2024 Third Quarter Financial Results
24/01/2024
SOUTH SAN FRANCISCO, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and [...]
ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo
24/01/2024
SOLANA BEACH, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine [...]
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
24/01/2024
Year-over-year revenue grows 12% , operating profit down 2% , non-GAAP operating profit up 20% Resumed share repurchase program, repurchased $50 million during quarter Note: A webcast of ResMed’s conference call will be [...]
UPDATE -- Visory Health Announces The Kroger Company As Preferred Pharmacy
24/01/2024
The prescription discount card has helped customers save over $5 billion on prescriptions at over 35,000 pharmacies nationwide ORLANDO, Fla., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Visory Health , a women-led, patient-first [...]
Transparency Notifications from Shareholders
24/01/2024
PRESS RELEASE REGULATED INFORMATION 24 January 2024, 06:00 pm CET Ghent, Belgium – 24 January 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the treatment of [...]
Top 40 High School Scientists in Prestigious Regeneron Science Talent Search to Compete for $1.8 Million in Awards
24/01/2024
Regeneron Science Talent Search Showcases Exceptional Young Leaders with Innovative Ideas in Science, Technology, Engineering and Math (STEM) TARRYTOWN, N.Y. and WASHINGTON, D.C., Jan. 24, 2024 (GLOBE NEWSWIRE) -- [...]
CORRECTION -- Sirona Biochem Corporate Update January 2024
24/01/2024
VANCOUVER, British Columbia, Jan. 24, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF), please note that in the 8th [...]
OrphAI Therapeutics Announces Appointment of Jay Fine to Board of Directors
24/01/2024
Seasoned leader in drug discovery and development GUILFORD, Conn., Jan. 24, 2024 (GLOBE NEWSWIRE) -- OrphAI Therapeutics Inc. (“OrphAI”) , a clinical-stage biopharmaceutical company developing novel therapeutics for [...]
Rejuvant Emerges as No. 1 Longevity Solution in TruMe Labs DNA Methylation Test Results
24/01/2024
FERNANDINA BEACH, Fla., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Ponce de Leon Health, the creators of Rejuvant , revealed vital insights for longevity enthusiasts in a LinkedIn post published by its founder and CEO, Tom [...]
500th Use of the Galaxy System™ in the United States Conducted at CHI Memorial in Tennessee
24/01/2024
The procedure marks an important achievement as the Noah Galaxy System’s imaging-integrated robot-assisted bronchoscopy solution continues to roll out to health systems and physicians across the U.S. SAN CARLOS, Calif [...]
PharmAla receives new “MDXXF” ticker from FINRA for OTCQB Listing
24/01/2024
New ticker symbol goes into effect immediately VANCOUVER, British Columbia, Jan. 24, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology [...]
Capricor Therapeutics Announces Collaboration with the National Institutes of Health for Clinical Trial of Novel Exosome-Based Multivalent Vaccine for SARS-CoV-2
24/01/2024
-Project NextGen Collaboration will Support Capricor’s StealthX™ Exosome Platform and Provide Non-Dilutive Support for Advancement into the Clinic- SAN DIEGO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics ( [...]
AIM ImmunoTech Receives Erasmus Medical Center Ethics Board Authorization for Phase 2 Study of Ampligen® for the Treatment of Locally Advanced Pancreatic Cancer
24/01/2024
Subject enrollment is expected in Q1 2024 OCALA, Fla., Jan. 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has received authorization from the [...]
HWH International Provides Business Status Update
24/01/2024
Bethesda, MD, Jan. 24, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. (Nasdaq: HWH) (“HWH”) is pleased to offer an update on HWH's business operations since the successful completion of the business combination on [...]
ProLynx announces a publication proposing that a long-acting prodrug of SN-38 could be effective in treating Sacituzumab Govitecan-Resistant Tumors
24/01/2024
SAN FRANCISCO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- ProLynx Inc., a biotech company with a unique technology for tunable half-life extension of drugs, announced publication of a paper entitled “Could a Long-Acting Prodrug [...]
Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment
24/01/2024
HAMILTON, BERMUDA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Altamira’s poly KRAS mut siRNA shown to knock down at least 65-91% of KRAS mutations in colorectal, non-small cell lung, and pancreatic cancer cell lines Fresh [...]
Immix Biopharma Statement On January 2024 FDA Labeling Change Notification For Approved CAR-T Products
24/01/2024
LOS ANGELES, CA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“Immix Biopharma”, “Company”, “We” or “Us”, Nasdaq:IMMX), a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune [...]
Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets
24/01/2024
Tailored Vaccines: With the AI-Immunology™ enabled discovery of these novel types of cancer vaccine targets, designing personalized and precision vaccine solutions becomes feasible and highly promising for patients in [...]

Pages